Navigation Links
NCPO: Medication and Counseling Vital for Healthcare Reform, Implementation and Future Patient Care Improvements
Date:5/28/2009

Improving patients' adherence to medications would improve lives, reduce costs

Washington, D.C. (Vocus) May 28, 2009 -- In a policy statement released today, the National Conference of Pharmaceutical Organizations (NCPO) called on Congress and the Administration to reap the full benefits of medications and medication counseling as they develop healthcare reform legislation and other policies.

The statement, titled "From Reform to Revolution: Maximizing the Power of Proper Medication Use in Patient Care," reflects a cohesive voice for associations in the pharmaceutical and pharmacy value chain. NCPO serves as a forum for the leadership of the American Association of Colleges of Pharmacy, the American Pharmacists Association, the American Society of Health-System Pharmacists, the Consumer Healthcare Products Association, the Generic Pharmaceutical Association, the Healthcare Distribution Management Association, the National Association of Chain Drug Stores, the National Association of Boards of Pharmacy, the National Community Pharmacists Association and the Pharmaceutical Research and Manufacturers of America.

"The use of prescription and over-the-counter medications fills an important role in meeting the public's healthcare needs," NCPO wrote in its policy statement. "We believe policymakers must consider the importance of access to medication therapy and appropriate counseling on the use of medications when developing health system reforms - including legislation, subsequent implementing regulations and future improvements."

"Providing access to prescription and over-the-counter medications, through a coordinated care approach involving the pharmacist working in collaboration with physicians and other healthcare providers, should be a central piece of any health reform agenda."

The policy statement described several statistics, including the estimated $177 billion in annual direct and indirect costs that result from poor medication adherence. "Poor adherence, particularly in the case of those with chronic diseases, leads to unnecessary disease progression, reduced functional status, a lower quality of life and premature death. These consequences of nonadherence to medications translate into increased usage of costly healthcare services, such as emergency department visits and hospitalizations," NCPO said.

NCPO recommended the following components of healthcare reform:

 
  • Every American should have access to the most appropriate clinically effective medications, whether they are available as a generic, brand or over-the-counter medication, as well as counseling on proper medication use and the importance of adherence to medication.

 
  • National goals for the improvement of health care quality should include evaluating provider performance through measurement, public reporting of quality measures, and providing incentives for improving patient outcomes.

 
  • Health systems focused on coordinated care should be available to all patients, with access to a care coordinator who can help them manage their health effectively and ensure compliance with prescription drug therapy.

 
  • Fair reimbursement to health care providers should include costs related to dispensing medications and pharmacist-provided care, such as medication therapy management (MTM). Providing services such as MTM is especially important to patients with chronic disease since chronic diseases are the number one cause of death and disability in the U.S. and treating patients with chronic conditions accounts for 75 percent of the nation's health care spending.

 
  • Health information technology, including electronic prescribing and electronic medical records, should be incorporated and used appropriately by providers to improve patient health outcomes, coordinate patient care, and aid in appropriate health research.

 
  • Preventive services such as healthcare screenings and immunizations, medication therapy management and disease management should be covered and promoted through outreach and education for optimal utilization.

 
  • Behaviors that promote health and wellness should be encouraged.

The National Conference of Pharmaceutical Organizations (NCPO) brings together the associations that represent those directly involved in patient care utilizing vital medications. The associations engaged in this collaborative forum include those focused on medication discovery, manufacturing and distribution, and those focused on pharmacy practice, education and oversight. Together, they foster advancements in the contributions of medications and pharmacists to society.

Contact:
Chrissy Kopple (NACDS)
For NCPO
(703) 837-4266

# # #

Read the full story at http://www.prweb.com/releases/NCPO/healthcare_reform/prweb2473294.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
2. Manic phase of bipolar disorder benefits from breast cancer medication
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. Mayo Clinic study indicates medication for ADHD may help student outcomes
5. Diet and medications may assist prevention of prostate cancer
6. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
7. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
8. Moses Taylor Hospital Automates Medication Reconciliation
9. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
10. Patients cant recall their medications to tell doctors
11. Patient Empowerment -- Medication Error
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... System and David Konur, CEO of Cardiovascular Institute of the South announced today ... be performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, ... Blue Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and ... Company; Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession of Aging ... our aging population has on communities and resources. Aging Life Care plays an important ... age-related challenges. , Aging Life Care is a holistic, client-centered approach to caring ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. ... announced a development collaboration with the Australian critical medicine company, Phebra Pty ... schizophrenia. , LAI medicines can offer improved therapeutic benefits over oral formulations, including ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... for electronic cigarettes, requiring e-cigarette manufacturers to submit their products through an arduous ... to all vaping products that entered the market since February 15, 2007. That ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocythemia Market and ... to their offering.       ... ,The latest research Europe Thrombocythemia Market ... provides comprehensive insights into Thrombocythemia pipeline ...
(Date:5/4/2016)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... First Quarter 2016 Highlights , Generated ... "Cash Flow") of $13.6 million for the first quarter ... million for the first quarter of 2016; , ...
(Date:5/4/2016)... 2016 According to market research "Global ... Forecast to 2022 - Industry Insights by Slice Type (High, ... Others)" by P&S Market Research, the global computed tomography ... it is expected to grow at a CAGR of 5.0% ... segment is expected to witness the faster growth, CAGR of ...
Breaking Medicine Technology: